15 . August , 2018 - Wednesday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Fludarabine Phosphate

Big Image Pronouncation: (flew-DAR-uh-BEAN)
Class: Purine antimetabolite

Trade Names:
- Powder for injection 50 mg

Mechanism of Action


Fludarabine is a fluorinated nucleotide analog of the antiviral agent vidarabine. Fludarabine's metabolite appears to act by inhibiting DNA polymerase alpha, ribonucleotide reductase, and DNA primase, thus inhibiting DNA synthesis.



Fludarabine is rapidly converted to the active metabolite, 2‐fluoro‐ara‐A, within minutes after IV infusion.


In vitro, plasma protein binding of fludarabine ranged between 19% and 29%.


The t ½ of 2‐fluoro‐ara‐A is approximately 20 h.


Renal Cl represents approximately 40% of the total body Cl.

Indications and Usage

Refractory or progressive chronic B-cell lymphocytic leukemia.

Unlabeled Uses

Leukemias, non-Hodgkin lymphoma.


Standard considerations.

Dosage and Administration

Chronic Lymphocytic Leukemia

IV 25/m 2 /day over approximately 30 min daily for 5 consecutive days. Each 5‐day course should commence every 28 days.

Renal Function Impairment

IV Reduce dose 20% in moderate renal function impairment (CrCl 30 to 70 mL/min/1.73 m 2 ). Do not administer in patients with severely impaired renal function (CrCl less than 30 mL/min/1.73 m 2 ).

Drug Interactions


Concomitant therapy may cause severe or fatal pulmonary toxicity.

Laboratory Test Interactions

None well documented.

Adverse Reactions


Deep venous thrombosis, phlebitis (at least 1%); aneurysm; angina; arrhythmia; cerebrovascular accident; CHF; MI; supraventricular tachycardia; transient ischemic attack.


Weakness (65%); fatigue (38%); paresthesia (12%); malaise (8%); agitation; coma; confusion; headache; weakness.


Rash (15%); diaphoresis (13%); pruritus (at least 1%); alopecia; seborrhea.


Visual disturbances (15%); hearing loss, sleep disorder (at least 1%); cerebellar syndrome; depression; impaired mentation.


Nausea/vomiting (36%); anorexia (34%); diarrhea (15%); GI bleeding (13%); constipation (at least 1%); dysphagia; esophagitis; mucositis; stomatitis.


Dysuria, hematuria; urinary infection (at least 1%); abnormal renal function test; hemorrhagic cystitis; proteinuria; renal failure; urinary hesitancy.


Anemia (60%); neutropenia (59%); thrombocytopenia (55%); autoimmune hemolytic anemia; pancytopenia (postmarketing).


Abnormal LFTs (at least 1%); cholelithiasis; liver failure.




Hyperglycemia (at least 1%); tumor lysis syndrome (including hyperuricemia, hyperphosphatemia, hypocalcemia, metabolic acidosis, hyperkalemia, hematuria, urate crystalluria, renal failure).


Myalgia (16%); arthralgia; osteoporosis.


Cough (44%); dyspnea, pneumonia (22%); hemoptysis, upper respiratory tract infections (at least 1%); allergic pneumonitis; bronchitis; epistaxis; hypoxia; pharyngitis; pulmonary hypersensitivity; sinusitis; respiratory distress, pulmonary hemorrhage, pulmonary fibrosis, respiratory failure (postmarketing).


Fever (69%); infection (44%); pain (22%); chills, edema (19%); dehydration; hemorrhage.



Neurotoxicity associated with high doses in dose ranging studies in acute leukemia. Autoimmune hemolytic anemia reported after at least 1 cycle. Concurrent use with pentostatin not recommended, based on increased incidence of fatal pulmonary toxicity. Severe CNS toxicity occurred in 36% patients receiving doses approximately 4 times greater than the recommended dose. (96 mg/m 2 /day for 5 to 7 days). At recommended doses, severe CNS toxicity is rare.

Bone marrow suppression

Severe bone marrow suppression, notably anemia, thrombocytopenia, and neutropenia, occurred.


Category D .




Safety and efficacy not established.

Renal Function

Administer cautiously.

Dose-dependent toxicity

There are clear dose-dependent toxic effects seen with fludarabine.


Transfusion-associated graft/host disease may occur after transfusion of non-irradiated blood.

Tumor lysis syndrome

Tumor lysis syndrome has occurred.



Irreversible CNS toxicity characterized by delayed blindness, coma, and death; severe thrombocytopenia and neutropenia.

Patient Information

  • Review the treatment regimen including dosing schedule, duration of treatment, and monitoring that will be required.
  • Advise patient, family, or caregiver that medication will be prepared and administered by health care providers in a health care setting.
  • Advise patient, family, or caregiver that medication may be used in combination with other agents to achieve maximum benefit possible.
  • Advise patient, family, or caregiver to immediately report any of the following to health care provider: rash; hives; difficulty breathing; fever, chills, or other signs of infection; bleeding or unusual bruising; sores in mouth; dark urine; yellowing of skin or eyes; pain, redness, or swelling at injection site.
  • Advise patient, family, or caregiver to report any of the following to health care provider: persistent nausea, vomiting, diarrhea, or appetite loss; persistent or worsening general body weakness.
  • Caution women of childbearing potential to avoid becoming pregnant during therapy.

Recent Drug Updates at DrugIndexOnline:

Chlorpheniramine/Phenylephrine Sustained-Release Capsules Chlorpheniramine/Phenylephrine Sustained-Release Capsules
Generic Name: Chlorpheniramine/Phenylephrine Sustained-Release Capsules (klor-fen-IHR-ah-meen/fen-il-EF-rin) Brand Name: Dallergy JRChlorpheniramine/Phenylephrine Sustained-Release Capsules is used for:Relieving symptoms of sinus congestion, sinus pressure, runny nose, and sneezing due to colds, more...

Detrol LA Detrol LA
Generic name: Tolterodine tartrate Brand names: Detrol LA, Detrol Why is Detrol LA prescribed? Detrol combats symptoms of overactive bladder, including frequent urination, urgency (increased need to urinate), and urge incontinence (inability to control urination). The drug works by blocking the more...

Dibenzyline Dibenzyline
Generic Name: Phenoxybenzamine (fen-ox-ee-BEN-za-meen) Brand Name: DibenzylineDibenzyline is used for:Treating high blood pressure and sweating caused by a certain kind of tumor (pheochromocytoma). It may also be used for other conditions as determined by your doctor. Dibenzyline is an alpha-b more...

Histex I/E Extended-Release Capsules Histex I/E Extended-Release Capsules
Generic Name: Carbinoxamine Maleate Extended-Release Capsules and Extended-Release Tablets (kar-bi-NOX-a-meen) Brand Name: Examples include Histex CT and Histex I/EHistex I/E Extended-Release Capsules is used for:Treating allergy symptoms such as runny nose, watery/itchy eyes, rash, or hives. I more...

Hyoscyamine Extended-Release Tablets Hyoscyamine Extended-Release Tablets
Generic Name: Hyoscyamine Extended-Release Tablets (HYE-oh-SYE-a-meen) Brand Name: Examples include Levbid and Symax SRHyoscyamine Extended-Release Tablets is used for:Treating certain stomach, intestinal, and bladder conditions, including spasms. It is used to control stomach secretions and cr more...

Invega Invega
Generic Name: Paliperidone Tablets (PAL-ee-PER-i-done) Brand Name: InvegaInvega is an atypical antipsychotic. It may increase the risk of death when used to treat mental problems caused by dementia in elderly patients. Most of the deaths were linked to heart problems or infection. Invega is no more...

Novolin ge Ultralente Novolin ge Ultralente
Some commonly used brand names are: In the U.S.— Humulin 50/50 14 Humulin 70/30 14 Humulin 70/30 Pen 14 Humulin L 10 Humulin N 13 Humulin N Pen 13 Humulin R 7 Humulin R, Regular U-500 (Concentrated) 7 Humulin U 5 Lente Iletin II 8 Lente 8 Novolin 70/30 14 Novolin L 10 Novolin N 13 Novolin more...

Nozinan Oral Drops Nozinan Oral Drops
Some commonly used brand names are: In the U.S.— Chlorpromazine Hydrochloride Intensol 1 Compazine 8 Compazine Spansule 8 Mellaril 11 Mellaril Concentrate 11 Mellaril-S 11 Permitil 2 Permitil Concentrate 2 Prolixin 2 Prolixin Concentrate 2 Prolixin Decanoate 2 Prolixin Enanthate 2 Serenti more...